Review



lovo cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ATCC lovo cell line
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Lovo Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 2930 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lovo cell line/product/ATCC
    Average 97 stars, based on 2930 article reviews
    lovo cell line - by Bioz Stars, 2026-03
    97/100 stars

    Images

    1) Product Images from "FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling"

    Article Title: FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling

    Journal: iScience

    doi: 10.1016/j.isci.2026.114662

    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and LOVO cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and LOVO cell lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Figure Legend Snippet: FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and LOVO cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and LOVO cell lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.

    Techniques Used: Western Blot, Expressing, Knockdown, CCK-8 Assay, Colony Assay, EdU Assay, Staining, Fluorescence, Apoptosis Assay

    FAM65A promotes CRC cell migration in vitro (A) Transwell migration assay was conducted to evaluate the migration capabilities of shCtrl and shFAM65A in SW480 and LOVO cell lines. Scale bars, 50 μm. (B) A quantitative analysis of the Transwell migration assay was performed, n = 3, ∗∗∗ p < 0.001. (C) The results of wound healing assay comparing shCtrl and shFAM65A in SW480 and LOVO cells were obtained. Scale bars, 50 μm. (D) A quantitative analysis of the wound healing assay was also conducted, n = 3, ∗∗∗ p < 0.001. (E) Western blot analysis was performed to assess the expression levels of EMT markers in SW480 and LOVO cells. Data are presented as mean ± SEM of biologically independent experiments.
    Figure Legend Snippet: FAM65A promotes CRC cell migration in vitro (A) Transwell migration assay was conducted to evaluate the migration capabilities of shCtrl and shFAM65A in SW480 and LOVO cell lines. Scale bars, 50 μm. (B) A quantitative analysis of the Transwell migration assay was performed, n = 3, ∗∗∗ p < 0.001. (C) The results of wound healing assay comparing shCtrl and shFAM65A in SW480 and LOVO cells were obtained. Scale bars, 50 μm. (D) A quantitative analysis of the wound healing assay was also conducted, n = 3, ∗∗∗ p < 0.001. (E) Western blot analysis was performed to assess the expression levels of EMT markers in SW480 and LOVO cells. Data are presented as mean ± SEM of biologically independent experiments.

    Techniques Used: Migration, In Vitro, Transwell Migration Assay, Wound Healing Assay, Western Blot, Expressing



    Similar Products

    97
    ATCC lovo cell line
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Lovo Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lovo cell line/product/ATCC
    Average 97 stars, based on 1 article reviews
    lovo cell line - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    ccl  (ATCC)
    97
    ATCC ccl
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Ccl, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl/product/ATCC
    Average 97 stars, based on 1 article reviews
    ccl - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    lovo  (ATCC)
    97
    ATCC lovo
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Lovo, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lovo/product/ATCC
    Average 97 stars, based on 1 article reviews
    lovo - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    97
    ATCC human colorectal adenocarcinoma lovo cells
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Human Colorectal Adenocarcinoma Lovo Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human colorectal adenocarcinoma lovo cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human colorectal adenocarcinoma lovo cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    97
    ATCC human colon adenocarcinoma lovo cells
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Human Colon Adenocarcinoma Lovo Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human colon adenocarcinoma lovo cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human colon adenocarcinoma lovo cells - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    97
    ATCC ccl 229 mda mb 231 atcc
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Ccl 229 Mda Mb 231 Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ccl 229 mda mb 231 atcc/product/ATCC
    Average 97 stars, based on 1 article reviews
    ccl 229 mda mb 231 atcc - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    99
    ATCC htb 38 lovo atcc
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Htb 38 Lovo Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/htb 38 lovo atcc/product/ATCC
    Average 99 stars, based on 1 article reviews
    htb 38 lovo atcc - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    97
    ATCC lovo atcc ccl 229 htc116 atcc ccl 247 caco2 atcc htb
    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and <t>LOVO</t> cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and <t>LOVO</t> <t>cell</t> lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.
    Lovo Atcc Ccl 229 Htc116 Atcc Ccl 247 Caco2 Atcc Htb, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lovo atcc ccl 229 htc116 atcc ccl 247 caco2 atcc htb/product/ATCC
    Average 97 stars, based on 1 article reviews
    lovo atcc ccl 229 htc116 atcc ccl 247 caco2 atcc htb - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    Image Search Results


    FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and LOVO cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and LOVO cell lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.

    Journal: iScience

    Article Title: FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling

    doi: 10.1016/j.isci.2026.114662

    Figure Lengend Snippet: FAM65A promotes CRC cell proliferation and inhibits cell apoptosis (A) Western blot analysis FAM65A expression in human normal colon cells and CRC cells was assessed. (B) Western blot analysis FAM65A knockdown efficiency in SW480 and LOVO cells. (C) CCK8 assay was performed with shCtrl and shFAM65A in SW480 and LOVO cell lines, n = 3, ∗∗∗ p < 0.001. (D) The outcomes of the colony formation assay for shCtrl and shFAM65A in SW480 and LOVO cells were reported. (E) A quantitative analysis of the colony formation assay was conducted, n = 6, ∗ p < 0.05, ∗∗ p < 0.01. (F) The results of the EdU assay for shCtrl and shFAM65A in SW480 and LOVO cells were presented, where EdU-positive stained cells exhibited green fluorescence and nuclei displayed blue fluorescence. Scale bars, 100 μm. (G) A quantitative analysis of the EdU assay results was performed, n = 3, ∗∗∗ p < 0.001. (H) The results of the apoptosis assay for shCtrl and shFAM65A in SW480 and LOVO cells were documented. Scale bars, 50 μm. (I) A quantitative analysis of the apoptosis assay was conducted, n = 3, ∗∗ p < 0.01, ∗∗∗ p < 0.001. (J) The western blot results for the expression of Ki-67, cleaved caspase 3, Bcl-2, and Bax in SW480 and LOVO cells for both shCtrl and shFAM65A were presented. Data are presented as mean ± SEM of biologically independent experiments.

    Article Snippet: LOVO cell line , ATCC , CCL-229.

    Techniques: Western Blot, Expressing, Knockdown, CCK-8 Assay, Colony Assay, EdU Assay, Staining, Fluorescence, Apoptosis Assay

    FAM65A promotes CRC cell migration in vitro (A) Transwell migration assay was conducted to evaluate the migration capabilities of shCtrl and shFAM65A in SW480 and LOVO cell lines. Scale bars, 50 μm. (B) A quantitative analysis of the Transwell migration assay was performed, n = 3, ∗∗∗ p < 0.001. (C) The results of wound healing assay comparing shCtrl and shFAM65A in SW480 and LOVO cells were obtained. Scale bars, 50 μm. (D) A quantitative analysis of the wound healing assay was also conducted, n = 3, ∗∗∗ p < 0.001. (E) Western blot analysis was performed to assess the expression levels of EMT markers in SW480 and LOVO cells. Data are presented as mean ± SEM of biologically independent experiments.

    Journal: iScience

    Article Title: FAM65A, as a potential predictor of prognosis, promotes colorectal cancer progression via activating Ras/ERK/RSK signaling

    doi: 10.1016/j.isci.2026.114662

    Figure Lengend Snippet: FAM65A promotes CRC cell migration in vitro (A) Transwell migration assay was conducted to evaluate the migration capabilities of shCtrl and shFAM65A in SW480 and LOVO cell lines. Scale bars, 50 μm. (B) A quantitative analysis of the Transwell migration assay was performed, n = 3, ∗∗∗ p < 0.001. (C) The results of wound healing assay comparing shCtrl and shFAM65A in SW480 and LOVO cells were obtained. Scale bars, 50 μm. (D) A quantitative analysis of the wound healing assay was also conducted, n = 3, ∗∗∗ p < 0.001. (E) Western blot analysis was performed to assess the expression levels of EMT markers in SW480 and LOVO cells. Data are presented as mean ± SEM of biologically independent experiments.

    Article Snippet: LOVO cell line , ATCC , CCL-229.

    Techniques: Migration, In Vitro, Transwell Migration Assay, Wound Healing Assay, Western Blot, Expressing